KR20050091162A - Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it - Google Patents
Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it Download PDFInfo
- Publication number
- KR20050091162A KR20050091162A KR1020040016328A KR20040016328A KR20050091162A KR 20050091162 A KR20050091162 A KR 20050091162A KR 1020040016328 A KR1020040016328 A KR 1020040016328A KR 20040016328 A KR20040016328 A KR 20040016328A KR 20050091162 A KR20050091162 A KR 20050091162A
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- derivatives
- weight
- liposomes
- nanoemulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 39
- 239000007908 nanoemulsion Substances 0.000 title claims abstract description 38
- 239000002537 cosmetic Substances 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 13
- 229940045997 vitamin a Drugs 0.000 title claims description 21
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims abstract description 52
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 36
- 239000011719 vitamin A Substances 0.000 claims abstract description 36
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 29
- 239000011718 vitamin C Substances 0.000 claims abstract description 29
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 26
- 239000011720 vitamin B Substances 0.000 claims abstract description 26
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 26
- 239000011709 vitamin E Substances 0.000 claims abstract description 26
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 30
- 238000009472 formulation Methods 0.000 claims description 29
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 25
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 25
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 20
- 239000006071 cream Substances 0.000 claims description 19
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 150000003904 phospholipids Chemical class 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 229940046001 vitamin b complex Drugs 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000004945 emulsification Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 37
- 230000003020 moisturizing effect Effects 0.000 description 16
- 235000016709 nutrition Nutrition 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 230000035764 nutrition Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000001953 sensory effect Effects 0.000 description 11
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 8
- 229930003270 Vitamin B Natural products 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 235000020944 retinol Nutrition 0.000 description 5
- 239000011607 retinol Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 229940108325 retinyl palmitate Drugs 0.000 description 4
- 235000019172 retinyl palmitate Nutrition 0.000 description 4
- 239000011769 retinyl palmitate Substances 0.000 description 4
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 4
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N beta-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- FCQAMVZGVMHDFT-UHFFFAOYSA-N butane-1,4-diol;propane-1,2,3-triol Chemical compound OCCCCO.OCC(O)CO FCQAMVZGVMHDFT-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- -1 lecithin phospholipid Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000004609 retinol derivatives Chemical class 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- MAANFGZQPVIMIP-UHFFFAOYSA-N butane-1,4-diol;propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCCCCO.OCC(O)CO MAANFGZQPVIMIP-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000008206 lipophilic material Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 150000003612 tocotrienol derivatives Chemical class 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45C—PURSES; LUGGAGE; HAND CARRIED BAGS
- A45C5/00—Rigid or semi-rigid luggage
- A45C5/02—Materials therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D3/00—Rigid or semi-rigid containers having bodies or peripheral walls of curved or partially-curved cross-section made by winding or bending paper without folding along defined lines
- B65D3/28—Other details of walls
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 비타민 A, B, C, E 및 그들의 유도체를 안정하게 함유한 나노에멀전과 리포좀의 제조방법 및 이를 함유한 화장료 조성물에 관한 것으로서, 보다 상세하게는 비타민 A, B, C, E 및 그들의 유도체를 카프릴릭/카프릭 트리글리세라이드와 함께 가온하여 혼합 용해한 후 냉각 단계를 거쳐 불포화레시틴 또는 포화레시틴을 혼합하고, 글리세롤, 알콜을 혼합 계량하여 정제수로 표준화하여 고압유화하여 제조된 것을 특징으로 하는 나노에멀전과 리포좀을 함유하는 화장료 조성물을 제공한다. 또한 비타민 A, B, C, E 및 그들의 유도체를 안정하게 함유한 나노에멀젼과 리포좀은 화장료 조성물 기준 0.1-50 중량%, 보다 바람직하게는 0.5-30 중량%인 것을 특징으로 하는 화장료 조성물 및 그의 제조방법을 제공한다. The present invention relates to a method for preparing nanoemulsions and liposomes stably containing vitamins A, B, C, E and derivatives thereof, and to cosmetic compositions containing the same, more specifically vitamins A, B, C, E and their The derivatives are heated and dissolved together with caprylic / capric triglycerides, and then dissolved and mixed with unsaturated lecithin or saturated lecithin through a cooling step, and mixed with glycerol and alcohol and standardized with purified water, followed by high pressure emulsification. Provided are cosmetic compositions containing nanoemulsions and liposomes. In addition, the nanoemulsion and liposomes stably containing vitamins A, B, C, E and derivatives thereof are 0.1-50% by weight, more preferably 0.5-30% by weight, based on the cosmetic composition and its preparation. Provide a method.
Description
본 발명은 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀의 제조방법 및 이를 함유한 화장료 조성물에 관한 것으로서, 보다 상세하게는 비타민 A, B, C, E 및 그들의 유도체를 최적의 비율로 레시틴 인지질 비지클에 봉입(encapsulation)하여 제조하는 것을 특징으로 하여 경시에 따른 안정성이 뛰어나며 피부 보습, 노화 방지 및 탄력 유지가 우수한 화장료 조성물 및 그의 제조방법에 관한 것이다. The present invention relates to a method for preparing nanoemulsions and liposomes containing vitamins A, B, C, E and derivatives thereof, and to cosmetic compositions containing the same, and more particularly to vitamins A, B, C, E and derivatives thereof. The present invention relates to a cosmetic composition having excellent stability over time and excellent skin moisturizing, anti-aging and elasticity maintaining, characterized in that it is prepared by encapsulation in a lecithin phospholipid vehicle at an optimal ratio.
급속한 산업화로 인하여 환경 오염이 심각해지고 이러한 환경오염이 인체에 미치는 유해한 영향에 대한 관심이 고조되고 있다. 특히 활성산소는 노화 및 암 발생의 주요 요인으로 지목되고 있으며, 크게 외부적 요인과 내부적 요인에 의해 생성되는 것으로 알려져 있다. 외부적 요인으로는 환경오염에 의하여 나타나는 여러 종류의 질소산화물과 산소산화물 형태인 이산화질소, 오존 등에 의한 것이고, 또 다른 요인으로서 자외선이 있다. Due to the rapid industrialization, environmental pollution is getting serious and attention is being paid to the harmful effects of such pollution on the human body. In particular, active oxygen is considered as a major factor of aging and cancer, and is known to be largely generated by external and internal factors. External factors are caused by various types of nitrogen oxides and oxygen oxides such as nitrogen dioxide and ozone, which are caused by environmental pollution, and another factor is ultraviolet rays.
자외선은 여러 종류의 활성산소를 생성시키며 이에 의해 세포 손상이 일어나 노화가 진행된다. 이와 같은 외부적 요인이외에도 생체내에서 일어나는 자발적 반응에 의해서도 활성산소가 생성되는데 생체내에는 이러한 활성산소를 제거하는 방어 기작이 존재하지만, 산화적 스트레스에 의해 세포가 손상되고 결과적으로 노화가 진행되는 것으로 알려져 있다. 이와 같은 이유로 특히 피부에서 일어나는 산화적 스트레스를 억제하고자 하는 많은 연구가 진행되었으며, 이에 따라 여러 항산화제가 개발되어 사용되고 있다. 이러한 물질로는 비타민 A (레티노익산), 비타민 C (아스코르빈산), 비타민 E (토코페롤) 등의 비타민류와 각종 동식물에서 추출한 플라보노이드 등이 알려져 있으며, 현재 화장료 등에 응용되어 사용되고 있다.Ultraviolet rays generate various kinds of free radicals, which cause cell damage and aging. In addition to such external factors, free radicals are generated by spontaneous reactions in vivo, but there are defense mechanisms to remove these free radicals in vivo, but oxidative stress damages cells and consequently ages. Known. For this reason, many studies have been conducted to suppress oxidative stress occurring in the skin, and various antioxidants have been developed and used accordingly. As such substances, vitamins such as vitamin A (retinoic acid), vitamin C (ascorbic acid), vitamin E (tocopherol) and flavonoids extracted from various plants and animals are known, and are currently used in cosmetics.
이 중 비타민 A, 비타민 C, 비타민 E는 지용성 내지 수용성 비타민으로 피부에 적용하였을 때 피부에서 일어나는 산화적 스트레스를 억제한다고 알려져 있다. 하지만 이러한 비타민류는 매울 불안정하여 화장료 조성물에 사용하는데 어려움이 있다. Among them, vitamin A, vitamin C, and vitamin E are fat-soluble to water-soluble vitamins and are known to suppress oxidative stress occurring in the skin when applied to the skin. However, these vitamins are very unstable and difficult to use in cosmetic compositions.
또한 나이가 들어감에 따라 피부의 탄력성이 감소하고 수분 보유량이 손실됨으로서 초래되는 피부 주름과 피부 건조화 등의 노화현상을 억제하는 방법은 화장료의 가장 큰 관심분야 중 하나로서 사람의 피부노화를 억제하는 물질로서 레티놀과 그의 유도체인 레티놀 팔미테이트는 잘 알려져 있으며, 이 물질을 유효성분으로 하는 피부외용제는 많이 있다. 예를 들어 레티놀을 콜라겐 합성 촉진제로 이용하는 화장재료가 특허출원 1996-40382호에 개시되어 있고, 레티놀에 안식향산 등의 방향족 카본산의 디에스테르를 미백성분으로 이용하는 미백화장료가 특허출원 1999-232호에 개시되어 있고, 레티놀을 유효성분으로 하는 멜라닌 생성 억제제가 특허출원 1998-19763호에 개시되어 있다. In addition, the method of suppressing aging such as skin wrinkles and skin drying caused by the decrease of elasticity of the skin and loss of moisture retention as it ages is one of the biggest interests of cosmetics, and it is a substance that suppresses human skin aging. Retinol and its derivatives, retinol palmitate, are well known and there are many external skin preparations using this substance as an active ingredient. For example, a cosmetic material using retinol as a collagen synthesis promoter is disclosed in Patent Application No. 1996-40382, and a whitening cosmetic using a diester of aromatic carbonic acid such as benzoic acid as a whitening ingredient in Patent Application No. 1999-232. The melanin production inhibitor which uses retinol as an active ingredient is disclosed by patent application 1998-19763.
레티놀 또는 레티놀 유도체는 콜라겐의 합성을 촉진하는 우수한 물질로서 이 물질을 주재료로 화장료, 피부외용제에 첨가하여 사용한 경우 우수한 콜라겐 합성 및 멜라닌 생성 억제 효과를 나타냄과 동시에 피부에 대한 어떠한 장해도 발생시키지 않는 피부제제용 화장료로 알려져 있다. 그러나 레티놀 또는 레티놀 유도체는 빛, 열, 공기, 수분 등에 의해 쉽게 산화되어 그 순수활성을 잃어버려 제품화하기 어려운 단점이 있다.Retinol or retinol derivative is an excellent substance that promotes the synthesis of collagen, and when it is used as a main ingredient in cosmetics and external skin preparations, it exhibits excellent collagen synthesis and melanin production inhibitory effect and does not cause any damage to the skin. Known cosmetic preparations. However, retinol or retinol derivatives are easily oxidized by light, heat, air, moisture, etc., and lose their pure activity, which makes them difficult to commercialize.
비타민 C는 각종 식품에 널리 포함되어 있는 항산화제로서, 감기의 예방 및 치료, 각종 암, 심장질환 등의 예방에 유용한 물질로 알려져 있다. 또한 비타민 C는 퀴논류를 페놀류로 환원시켜 티로시나아제 활성을 저해하는 효과가 있어 티로시나아제 활성에 높은 저해 효과를 보이며, 따라서 미백 제품 또는 기미, 주근깨 개선제의 원료로도 많이 이용되고 있다. 그러나 비타민 C 또한 제형물 중에서 불안정한 경향이 있어 열, 공기, 수분 등에 의해 쉽게 산화되어 피부에 자극을 유발하며 이를 포함한 화장료 조성물의 안정성이 2번 탄소 위치의 히드록시기가 산화되어 카르복실기로 변화되면서 일어나는 자동산화를 거쳐 특유의 색깔을 띠게 되어 제품 변색의 원인이 되는 단점을 가지고 있어 그 사용이 제한되고 또한 그 효과도 시간이 경과함에 따라 현저하게 떨어지는 단점이 있다.Vitamin C is an antioxidant widely used in various foods, and is known to be useful for the prevention and treatment of colds, various cancers, and heart disease. In addition, vitamin C has a high inhibitory effect on tyrosinase activity by reducing the quinones to phenols, and thus is widely used as a raw material for whitening products, blemishes, and freckles. However, vitamin C also tends to be unstable in the formulation, which is easily oxidized by heat, air and moisture, causing irritation to the skin. It has a disadvantage that causes a discoloration of the product due to the distinctive color, and its use is limited, and the effect is also significantly reduced over time.
따라서 지금까지 이러한 효과가 우수한 비타민류에 대한 안정성을 증대시키고자 다중유화(Multiple Emulsion)이나 액정 시스템(Liquid Crystal System), 비수유화(Non-Aqua Emulsion), 사이클로덱스트린으로 포접시키는 등의 에멀전 기술을 이용하여 경시에 따른 안정성을 향상시키고자 하는 노력이 진행되었다. Therefore, in order to increase the stability of vitamins having such excellent effects, emulsion techniques such as multiple emulsion, liquid crystal system, non-aqua emulsion, and cyclodextrin are included. Efforts have been made to improve the stability over time.
그러나 이러한 기술들은 여러 제형에 사용하는 데 한계가 많고, 수용성과 지용성 비타민을 모두 안정화시키는 데 어려움이 있었다. However, these techniques have many limitations for use in many formulations and have difficulty stabilizing both water-soluble and fat-soluble vitamins.
본 발명은 이와 같은 종래의 문제점을 극복하고자 하는 것으로서, 비타민 A, B, C, E 및 그들의 유도체를 안정하게 함유한 나노에멀전과 리포좀을 함유한 화장료 조성물을 제공하여 피부 보습과 노화 예방 및 탄력 유지 효과가 우수한 화장료 조성물을 제공하고자 한다. The present invention is to overcome such a conventional problem, by providing a cosmetic composition containing nanoemulsion and liposomes stably containing vitamins A, B, C, E and derivatives thereof to moisturize skin, prevent aging and maintain elasticity It is intended to provide an excellent cosmetic composition.
이하 본 발명에 대해 상세히 설명하기로 한다.Hereinafter, the present invention will be described in detail.
비타민 A 및 그의 유도체인 레티놀 팔미테이트는 콜라겐 합성을 도와주는 것으로 알려져 있으며, 레티놀 유도체로서는 비타민 A의 모노지방산에스테르, 예를 들면 비타민 A 모노팔미테이트, 비타민 A 모노부틸레이트, 비타민 A 모노스테아레이트, 비타민 A 모노신나모에이트, 비타민 A 모노벤조에이트 등을 사용할 수 있고, 비타민 A 디지방산에스테르, 예를 들면, 비타민 A 디팔미테이트, 비타민 A 디부틸레이트, 비타민 A 디스테아레이트, 비타민 A 모노벤조에이트 등이 포함된다. Vitamin A and its derivatives, retinol palmitate, are known to aid collagen synthesis. Retinol derivatives include mono fatty acid esters of vitamin A, such as vitamin A monopalmitate, vitamin A monobutylate, vitamin A monostearate, Vitamin A monocinnamoate, vitamin A monobenzoate and the like can be used, and vitamin A difatty acid esters such as vitamin A dipalmitate, vitamin A dibutylate, vitamin A distearate, and vitamin A monobenzo Eight, etc. are included.
비타민 E는 토코페롤, 토코트리에놀 유도체들을 칭하며, 생리적 활성을 목적으로 분류하면 알파, 베타, 델타-토코페롤이 중요하다. 이들의 인체에 대한 생화학적 기전은 아직 완전히 규명되지 않았지만, 세포벽을 보호한다고 잘 알려져 있다. 세포벽은 인지질, 콜레스테롤, 중성지방이 주요 구성성분을 이루고 있는데, 비타민 E는 항산화제로서 세포벽의 주요성분을 유리된 라디칼로부터 보호해주는 역할을 한다. 즉 다가불포화지방이 산화되지 않도록 보호해준다. 비타민 E 및 그의 유도체가 안정성 측면에서 많이 이용되고 있으며 유도체로서는 아세테이트 또는 숙시네이트 형태로 에스테르된 것이 일반적으로 포함된다.Vitamin E refers to tocopherol and tocotrienol derivatives, and alpha, beta, and delta-tocopherol are important when classified for physiological activity. Their biochemical mechanisms for the human body have not yet been fully elucidated, but they are well known for protecting cell walls. Phospholipids, cholesterol and triglycerides are the major components of the cell wall. Vitamin E is an antioxidant that protects the major components of the cell wall from free radicals. This protects polyunsaturated fats from oxidation. Vitamin E and its derivatives are widely used in terms of stability, and derivatives generally include esters in the form of acetate or succinate.
한편 비타민 C는 유리기를 제거시켜주는 항산화제이며 거의 모든 면역기능을 강화시켜 주는 역할을 한다. 비타민 C는 과도한 태양광선에 노출되었을 때 생기는 유해산소가 피부를 손상시키는 것을 막아주는 항산화 효과가 우수하다. 또한 콜라겐 섬유의 합성을 촉진시킨다.Vitamin C, on the other hand, is an antioxidant that removes free radicals and boosts almost all immune function. Vitamin C is an antioxidant that protects your skin from the harmful oxygen produced when exposed to excessive sunlight. It also promotes the synthesis of collagen fibers.
순수한 형태의 비타민 C는 공기와 열, 금속, 빛, 알칼리 등에 의해 쉽게 파괴되는 단점이 있다. 그래서 비타민 C와 그의 유도체는 마그네슘 아스코르빌 포스페이트, 소디움 아스코르빌 포스페이트 및 에틸 아스코르빌 에테르 등의 각종 아스코르빈산 유도체가 합성되었다. 그러나 수용액에 녹는 성질로 인하여 피부 진피층까지 흡수되는 경피흡수율이 낮고 지속적으로 효과를 유지하기가 어렵다.Vitamin C in its pure form has the disadvantage of being easily destroyed by air, heat, metal, light and alkali. Thus, ascorbic acid derivatives such as magnesium ascorbyl phosphate, sodium ascorbyl phosphate and ethyl ascorbyl ether were synthesized as vitamin C and its derivatives. However, due to its dissolving property in the aqueous solution, the percutaneous absorption rate absorbed to the dermal layer of the skin is low and it is difficult to maintain the effect continuously.
비타민 B는 단일 비타민이 아니라 비타민 B1, B2, B3, B5, B6 등 다양한 군으로 나누어져 있으며 비타민 B 복합체를 형성한다. 비타민 B가 부족하면 정상적인 당과 지방의 대사를 방해해 여드름이 생기고 피부가 거칠어진다.Vitamin B is not a single vitamin but is divided into various groups such as vitamins B1, B2, B3, B5, and B6, and forms a vitamin B complex. Lack of vitamin B can interfere with normal sugar and fat metabolism, leading to acne and rough skin.
특히 비타민 B5는 판테놀이라고 불리우며 보습과 피부진정효과가 우수하다. 또한 건조하고 거친 피부에 큰 도움을 준다. In particular, vitamin B5 is called panthenol and has excellent moisturizing and soothing effects. It is also a great help for dry and rough skin.
따라서 본 발명은 기술한 비타민의 기능에 주목하여 비타민 A, B, C, E 및 그들의 유도체를 화장품에 함유시키고, 이를 피부에 장기 보존성을 높여서 효과를 지속시키는 장점을 집중적으로 연구하였다.Therefore, the present invention focused on the functions of the described vitamins, vitamins A, B, C, E and their derivatives in cosmetics, and focused on the advantages of maintaining the effect by increasing the long-term preservation in the skin.
지금까지 알려진 바에 따르면 화장료 조성에서 수분과 유효 생리활성 성분을 효과적으로 피부에 침투시키기에 가장 적합한 구조는 리포좀과 나노에멀전이다.As far as is known, the most suitable structures for the effective penetration of moisture and active bioactive ingredients into the skin in cosmetic compositions are liposomes and nanoemulsions.
리포좀이란 자기 스스로 회합하는 콜로이드 입자들의 구형 인지질 비지클로서 친수성 부분과 친유성 부분을 가진 양친매성 분자의 상호작용에 의해 자발적으로 정렬된 구조를 만든다.Liposomes are spherical phospholipid vehicles of self-associating colloidal particles that form spontaneously aligned structures by the interaction of amphiphilic molecules with hydrophilic and lipophilic moieties.
일반적으로 리포좀은 밀폐형의 이중막 구조로서 수용성 핵 내부에 친수성 물질을 함유할 수 있고, 양친매성 물질 또는 친유성 물질들을 지질 이중층 내부에 함유할 수 있다. In general, liposomes are hermetically sealed double membrane structures that may contain a hydrophilic material inside the water-soluble nucleus, and may contain amphiphilic or lipophilic materials within the lipid bilayer.
나노에멀전이란 인지질의 단분자층에 의해 형성되는 입자의 평균직경이 30 내지 500 nm인 비지클로서 물속에 기름이 분산된 O/W형은 내부에 지용성 핵을 가진다. A nanoemulsion is a vehicle having an average diameter of 30 to 500 nm of particles formed by a monomolecular layer of phospholipid. The O / W type in which oil is dispersed in water has a fat-soluble core therein.
본 발명은 나노에멀전과 리포좀의 인지질 막의 형성에 불포화레시틴 및 포화 레시틴을 사용한다. 불포화레시틴 및 포화레시틴은 각질층을 유화시켜 소수성 분자의 피부 투과를 촉진한다. The present invention uses unsaturated lecithin and saturated lecithin in the formation of phospholipid membranes of nanoemulsions and liposomes. Unsaturated lecithin and saturated lecithin emulsify the stratum corneum to promote skin penetration of hydrophobic molecules.
본 발명에 따른 나노에멀전과 리포좀은 비타민 A 및 그의 유도체와 비타민 E 및 그의 유도체를 1:4의 비율로 0.01-10 중량%, 비타민 B와 비타민 C 및 그의 유도체를 1:1의 비율로 0.01-10 중량%로 함유한다. The nanoemulsion and liposomes according to the present invention are 0.01-10% by weight of vitamin A and its derivatives and vitamin E and its derivatives in a ratio of 1: 4, and 0.01-0.1% of vitamin B and vitamin C and its derivatives in a ratio of 1: 1-. It is contained in 10% by weight.
또한 본 발명에 따른 나노에멀전과 리포좀은 나노에멀전과 리포좀 총 중량에 대하여 불포화레시틴과 포화레시틴이 4:1의 비율로 1-15 중량%가 함유되고, 카프릴릭/카프릭트리글리세라이드, 글리세롤, 알콜이 20-50중량%로 혼합된다. In addition, the nanoemulsion and liposome according to the present invention contains 1-15% by weight of unsaturated lecithin and saturated lecithin in a ratio of 4: 1 to the total weight of the nanoemulsion and liposome, caprylic / capric triglyceride, glycerol, Alcohol is mixed at 20-50% by weight.
본 발명에 따른 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀을 함유한 화장료 조성물은 0.1-50 중량% 나노에멀전과 리포좀을 함유하며, 보다 바람직하게는 0.5-30 중량% 나노에멀전과 리포좀을 함유하는 것을 특징으로 한다.Cosmetic compositions containing nanoemulsions and liposomes containing vitamins A, B, C, E and derivatives thereof according to the invention contain 0.1-50% by weight nanoemulsions and liposomes, more preferably 0.5-30% by weight. It is characterized by containing a nanoemulsion and liposomes.
실시예와 제형예를 통하여 본 발명을 더욱 구체적으로 설명하고자 하나, 본 발명을 이에 한정하고자 하는 것은 아니다. Although the present invention will be described in more detail with reference to Examples and Formulation Examples, the present invention is not intended to be limited thereto.
실시예 1Example 1
나노에멀전과 리포좀의 제조에는 고압유화장치로서 마이크로플루다이저 (Microfluidizer)를 사용하는 공지의 고압균질 혼합 방법이 사용된다.In the preparation of nanoemulsions and liposomes, a known high pressure homogeneous mixing method using a microfluidizer as a high pressure emulsifier is used.
구체적인 제조예는 다음과 같다.Specific manufacturing examples are as follows.
하기 표 1과 같은 조성으로 비타민 A 팔미테이트 0.5 중량%, 비타민 E 아세테이트 2.5 중량%, 소디움 아스코르빌 포스페이트 2.0 중량%, 비타민 B 2.5 중량%, 카프릴릭/카프릭 트리글리세라이드 8.0 중량%를 섭씨 70도까지 가온하여 혼합 용해한 후 냉각시켰다. 여기에 유화제로서 불포화 레시틴 및 포화레시틴의 혼합액 15 중량%를 혼합하고 글리세롤 10 중량%, 알콜 5 중량%를 혼합한 후 정제수를 가하여 중량 100%로 만들었다. 혼합된 용액을 1,200 bar의 압력 조건하에서 고압유화장치에 3회 통과시켜 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀을 얻었다. To the composition shown in Table 1, 0.5% by weight of vitamin A palmitate, 2.5% by weight of vitamin E acetate, 2.0% by weight of sodium ascorbyl phosphate, 2.5% by weight of vitamin B, and caprylic / capric triglyceride 8.0% by weight Warmed to 70 degrees, mixed, dissolved, and cooled. 15% by weight of a mixture of unsaturated lecithin and saturated lecithin as an emulsifier were mixed, 10% by weight of glycerol and 5% by weight of alcohol were added thereto, and then purified water was added to make 100% by weight. The mixed solution was passed through a high pressure emulsifier three times under pressure conditions of 1,200 bar to obtain nanoemulsions and liposomes containing vitamins A, B, C, E and their derivatives.
상기 제조예에 의해 제조된 나노에멀전과 리포좀을 섭씨 40도 항온조에서 보관 후 제형안정성 및 HPLC를 이용하여 경시안정성을 측정하여 표 2과 표 3에 나타내었다. The nanoemulsion and liposomes prepared by the above preparation were stored in a 40 ° C. incubator, and then measured with stability of formulation and time-lapse stability using HPLC.
양호 : ○, 보통 : △, 불량 : × Good: ○, Normal: △, Poor: ×
실시예와 비교예에 의해 제조된 나노에멀전과 리포좀의 제형안정성 및 경시안정성을 관찰한 결과, 실시예가 실시비교예보다 제형안정성과 경시안정성이 보다 우수한 결과를 얻었다. 특히 불포화레시틴과 포화레시틴을 4:1의 비율로 조합하였을 때 제형안정성 및 경시안정성이 매우 우수한 것으로 나타났다. As a result of observing the formulation stability and time-lapse stability of the nanoemulsion and liposomes prepared according to the examples and the comparative example, the Example showed better formulation stability and time-lapse stability than the comparative example. Particularly, when the unsaturated lecithin and saturated lecithin were combined at a ratio of 4: 1, the formulation stability and aging stability were excellent.
이하 제형예를 들어 상기 실시예 1에서 제조된 비타민 A, B, C, E 및 그들의 유도체를 함유한 리포좀과 나노에멀전을 함유하는 화장료의 구성을 보다 구체적으로 설명한다. 그러나 본 발명은 다음의 영양크림, 영양로션, 유연화장수의 제형예에 한정하는 것은 아니고, 수렴화장수, 아이크림, 맛사지크림, 클린싱크림, 클린징폼, 클린싱워터, 팩 등의 제형으로도 가능하다.Hereinafter, the composition of the cosmetics containing the liposomes and nanoemulsions containing vitamins A, B, C, E and derivatives thereof prepared in Example 1 will be described in more detail. However, the present invention is not limited to the following formulations of nutrition cream, nutrition lotion and softening longevity, but can also be used in formulations of astringent makeup water, eye cream, massage cream, cleansing cream, cleansing foam, cleansing water, pack and the like.
제형예 1Formulation Example 1
영양크림의 제조Preparation of Nutritional Cream
하기 표 4의 조성으로 피부 표면에 보호유막을 제공하는 A상을 섭씨 70도까지 가온하고 일정 속도로 교반하고, 보습성분인 B상을 섭씨 75도까지 가온하고 일정속도로 교반한 후 B상을 A상에 서서히 투입하면서 유화시켰다. C상을 (A+B)상에 투입한 후 서서히 냉각, 여과한 후 숙성하여 용기에 충전하였다. The phase A, which provides a protective oil film on the skin surface with the composition of Table 4, is heated to 70 degrees Celsius and stirred at a constant speed. It was emulsified while slowly adding to phase A. Phase C was added to (A + B) phase, then slowly cooled, filtered and aged to fill the vessel.
제형예 2Formulation Example 2
영양화장수의 제조Preparation of Nutrients
하기 표 5의 조성으로 피부 표면에 보호유막을 제공하는 A상을 섭씨 70도까지 가온하고 일정속도로 교반하고, 보습성분인 B상을 섭씨 75도까지 가온하고 일정속도로 교반한 후 B상을 A상에 서서히 투입하면서 유화시켰다. C상을 (A+B)상에 투입한 후 서서히 냉각, 여과한 후 숙성하여 용기에 충전하였다. The phase A, which provides a protective oil film on the skin surface with the composition of Table 5, is heated to 70 degrees Celsius and stirred at a constant speed. It was emulsified while slowly adding to phase A. Phase C was added to (A + B) phase, then slowly cooled, filtered and aged to fill the vessel.
제형예 3Formulation Example 3
유연화장수의 제조방법Manufacturing method of flexible cosmetics
하기 표 6의 조성으로 B, A, C, D를 순서대로 넣고, 일정속도로 교반하여 혼합하였다.B, A, C, and D were sequentially added to the composition of Table 6, followed by stirring at a constant speed to mix.
본 발명에 따른 화장료의 효능조사 시험Efficacy test of cosmetics according to the present invention
상기 3가지 제형예 및 비교예에 따라 제조한 내용물 각각에 대하여 보습능 및 일반관능시험을 25-45세의 여성 20명을 대상으로 기기측정 및 비교품평을 실시하였다.For each of the contents prepared according to the three formulation examples and comparative examples, the measurement and comparative evaluation of the moisturizing ability and general sensory test was performed on 20 women aged 25-45 years.
시험예 1Test Example 1
보습효과 시험Moisturizing effect test
상기 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전 또는 리포좀을 함유한 화장료에 대한 피부보습 효과를 측정하였다.The skin moisturizing effect of the nanoemulsion or liposome containing the vitamin A, B, C, E and derivatives thereof was measured.
섭씨 25도, 상대습도 45%, 공기의 흐름이 없는 실내에서 건강한 여성 10명을 오른쪽, 왼쪽 전주와 하방 5cm 되는 위치에 오른쪽을 대상으로는 실시예를, 왼쪽을 대상으로는 비교 실시예를 상기 표 4에 따라 제형하여 팔의 전주와 하방 5cm 되는 위치에 1일 2회 7일간 도포한 후 Corneometer CM 825 (CK Courage & Khazaka Germany)를 이용하여 표피 수분량에 따른 전기전도도의 변화로 0에서 150까지 피부의 수분량을 수치화하여 피부에서 수분량을 5회 연속 측정하여 평균값을 측정치로 보습효과를 측정하였다. 실험결과는 하기 표 7에 나타내었다.10 healthy women in a room with 25 degrees Celsius, 45% relative humidity and no flow of air recalled the example on the right and the left on the left and the comparative example on the left Formulated according to Table 4 and applied twice a day for 7 days at the position of 5cm below the forearm and the lower arm, and using the Corneometer CM 825 (CK Courage & Khazaka Germany) to change the electrical conductivity according to the epidermal moisture content from 0 to 150 Moisturizing effect was measured by measuring the moisture content of the skin five times in a row and quantifying the moisture content of the skin. The experimental results are shown in Table 7 below.
시험결과, 본 발명의 실시예는 1회 사용직후 42.1, 3일 사용 후 58.7, 6일 사용 후 69.7, 9일 사용 후 77.2의 수분량이 평균 측정되어 비교실시예와 비교하여 매우 향상된 효과를 나타내었으며, 지속적으로 사용할수록 비교실시예의 화장료에 비해 더욱 더 뚜렷한 보습능 증대 효과를 나타내었다. As a result of the test, the Examples of the present invention showed a very improved effect compared to the Comparative Example, the average amount of water was measured 42.1, 58.7 after 3 days, 69.7 after 6 days, 77.2 after 9 days after one use. As a result, the moisturizing ability was more pronounced than the cosmetics of the comparative example.
시험예 2Test Example 2
피부 안전성 실험Skin safety testing
상기 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀을 함유한 화장료에 대한 피부 안전성 실험을 실시하였다.Skin safety experiments were carried out on the nanoemulsions containing the vitamins A, B, C, E and their derivatives and the cosmetics containing liposomes.
피부 안전성 실험은 실시예와 비교실시예를 제품 원액 그대로 사용해, 건강한 남, 여 30명의 팔뚝에 패치 테스트용 반창고를 사용해 24시간 패치 테스트를 실시하였다.In the skin safety experiment, the test sample was used as it is and the comparative example was used, and a patch test bandage was performed on the forearm of 30 healthy males and females for 24 hours.
관찰은 반창고를 제거하여 4시간 후 피부에 나타나는 홍반 이상의 반응을 일으킨 사람을 양성자라고 하였다. The observation revealed that the proton was a person who had removed the band-aid and developed a erythema after 4 hours.
피부 자극도 산정 방법 :How to calculate the skin irritation:
피부자극도 = (자극도×반응을 나타낸 피시험자 수)/총 피시험자 수 Skin irritation degree = (number of subjects showing stimulation rate × response) / total number of subjects
피부 안전성 실험 결과 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀을 함유한 영양크림 (제형예 1)은 평균 자극정도가 0으로 피검자 전원에서 자극을 보이지 않아 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀이 피부에 자극이 없는 안전한 물질임을 알 수 있었다. As a result of skin safety test, the nutritional cream containing nanoemulsion and liposome containing vitamin A, B, C, E and their derivatives (Formulation Example 1) had a mean stimulation level of 0 and showed no stimulation in all the subjects. Nanoemulsions and liposomes containing, C, E and their derivatives were found to be safe substances with no irritation to the skin.
시험예 3Test Example 3
보습 효과 관능 시험Moisturizing effect sensory test
전술한 제형예 및 비교예에 따라 제조한 영양크림, 영양로션, 유연화장수에 대해 보습효과를 25-45세의 여성 20명을 대상으로 1일 2회 7일간 사용후 5점 척도 비교 품평을 하였다. 피부 보습이 향상되었는가라는 질문에 대해 '전혀 그렇지 않다-1점', '그렇지 않다-2점', '보통이다-3점', '그렇다-4점', '매우 그렇다-5점'으로 품평하도록 하였고, 적용시점은 제품의 1회 사용 직후와 1일 2회 10일간 사용 후로 나누어 비교 품평하였다. 그 결과는 표 10에 나타내었다. The moisturizing effect on nutrition cream, nutrition lotion and softening lotion prepared according to the above formulation example and comparative example was compared to 5-point scale after 20-day use twice a day for 20 women aged 25-45 years. . Regarding the question of whether skin moisturization has improved, it is criticized as 'not at all-1', 'not at most-2', 'normal is-3', 'yes-4' and 'very yes-5' The time point of application was comparatively divided by immediately after one use of the product and two days after use for 10 days. The results are shown in Table 10.
종합 점수 = {(매우만족인원수×5)+(만족인원수×4)+(보통인원수×3)+(나쁨인원수×2)+(매우나쁨인원수×1)}÷평가인원수 Overall score = {(very satisfied people × 5) + (satisfied people × 4) + (normal people × 3) + (bad people × 2) + (very bad people × 1)} ÷ evaluation people
시험예 4Test Example 4
탄력 효과 관능 시험 Elasticity effect sensory test
전술한 제형예 및 비교예에 따라 제조한 영양크림, 영양로션, 유연화장수에 대해 탄력효과를 25-45세의 여성 20명을 대상으로 1일 2회 10일간 사용 후 5점 척도 비교 품평하였다. 피부 탄력이 향상되었는가라는 질문에 대해 '전혀 그렇지 않다-1점', '그렇지않다-2점', '보통이다-3점', '그렇다-4점', '매우 그렇다-5점'으로 품평하도록 하였고, 적용시점은 제품의 1회 사용 직후와 1일 2회 7일 사용후로 나누어 비교 품평하였다. 그 결과는 표 11에 나타내었다. The elasticity effect on the nutrition cream, nutrition lotion, and supple cosmetics prepared according to the above-described formulation example and comparative example was compared and evaluated five-point scale after use twice daily for 10 women for 25-45 years. Regarding the question of whether skin elasticity is improved, it is criticized as 'not at all-1', 'not at most-2', 'normal at-3', 'yes at 4' and 'very yes at 5' The time point of application was comparatively divided after immediately using the product once and after using it twice a day for 7 days. The results are shown in Table 11.
종합 점수 = {(매우만족인원수×5)+(만족인원수×4)+(보통인원수×3)+(나쁨인원수×2)+(매우나쁨인원수×1)}÷평가인원수 Overall score = {(very satisfied people × 5) + (satisfied people × 4) + (normal people × 3) + (bad people × 2) + (very bad people × 1)} ÷ evaluation people
표 10과 표 11은 피험자가 직접 사용해 보고 느끼는 관능으로 인지한 제품 효과를 평가한 것이다. 이와 같이 피험자의 관능으로 평가한 수치는 5점 만점으로 하여 20명의 평균을 내어 수치화하였다. 피험자들이 평가한 수치는 높을수록 만족도가 높은 제품으로 만족도는 곧 제품이 우수함을 말해준다고 할 것이다.Tables 10 and 11 assess the product effects perceived by the subject's direct use and feel. In this way, the sensory sensory evaluations were performed on a scale of 5 out of 5 for the average of 20 people. The higher the scores of the subjects were, the higher the satisfaction was.
본 발명의 제형예 1에 의해 제조된 영양크림을 예로 설명하면, 제형예 1에 의해 제조된 영양크림은 보습 효능에 대한 관능평가가 사용직후 및 1일 2회 7일 사용후가 각각 3.9 및 4.6으로서 비교제형예 1에 의해 제조된 영양크림의 보습 효능에 대한 관능평가 3.6 및 4.1에 비해 지속적인 사용에 의해 우수한 효과를 얻을 수 있었다.Referring to the nutritional cream prepared by Formulation Example 1 of the present invention as an example, the nutritional cream prepared by Formulation Example 1 was 3.9 and 4.6 immediately after the use of the sensory evaluation on the moisturizing efficacy and after 7 days of use twice a day, respectively. As a result, excellent effects were obtained by continuous use as compared to sensory evaluation 3.6 and 4.1 for the moisturizing efficacy of the nutrition cream prepared in Comparative Formulation Example 1.
탄력 증가에 대한 관능평가는 비교예 1의 영양크림은 사용 직후 및 1일 2회 사용 후가 각각 3.0 및 3.5임에 비해, 제형예 1의 영양크림은 각각 3.3 및 4.5여서 본 발명의 비타민 A, B, C, E 및 그들의 유도체를 함유한 리포좀 또는 나노에멀전을 함유한 화장료는 피부보습능력 및 탄력증가 효과에 있어서 우수한 효과가 있음을 알 수 있었다. The sensory evaluation of the increase in elasticity is that the nutrition cream of Comparative Example 1 is 3.0 and 3.5 immediately after use and twice daily use, whereas the nutrition cream of Formulation Example 1 is 3.3 and 4.5, respectively, so that vitamin A, It was found that the cosmetics containing liposomes or nanoemulsions containing B, C, E and derivatives thereof had excellent effects on skin moisturizing ability and elasticity increasing effect.
이상 설명한 바와 같이 비타민 A, B, C, E 및 그들의 유도체를 함유한 나노에멀전과 리포좀을 함유한 화장료는 피부 보습 효과, 탄력 증가 효과 및 일반 관능 사용성에서 통상적인 비교제형예와 비교시 보다 향상된 효과를 나타내었으며, 특히 지속적으로 사용하는 경우 보다 우수한 효과를 나타내었다.As described above, the cosmetics containing nanoemulsions and liposomes containing vitamins A, B, C, E and derivatives thereof have an improved effect on skin moisturizing effect, elasticity increasing effect and general sensory use compared with conventional comparative formulations. In particular, it showed an excellent effect than the continuous use in particular.
이와 같이 본 발명은 피부에 효과적으로 작용하여 피부의 보습 능력, 탄력 증가를 통하여 건강한 피부를 유지하는데 유효하다는 것을 알 수 있다. As described above, it can be seen that the present invention is effective for maintaining healthy skin by effectively acting on the skin and increasing skin's moisturizing ability and elasticity.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040016328A KR20050091162A (en) | 2004-03-11 | 2004-03-11 | Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040016328A KR20050091162A (en) | 2004-03-11 | 2004-03-11 | Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050091162A true KR20050091162A (en) | 2005-09-15 |
Family
ID=37272891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020040016328A Withdrawn KR20050091162A (en) | 2004-03-11 | 2004-03-11 | Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20050091162A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1985280A2 (en) | 2007-04-27 | 2008-10-29 | Mibelle AG | Cosmetic product for topical use for protecting and renewing skin stem cells derived from dedifferentiated plant cells |
| CN103520101A (en) * | 2013-10-14 | 2014-01-22 | 陕西科技大学 | Vitamin A nano-emulsion and preparation method thereof |
| CN106821789A (en) * | 2017-03-30 | 2017-06-13 | 武汉润禾生物医药有限公司 | A kind of preparation method of B B-complex nourishing cream and its liposomal thing |
| CN110623858A (en) * | 2019-08-28 | 2019-12-31 | 上海克琴科技有限公司 | A kind of preparation method and application of vitamin A nano inclusion |
| CN112006924A (en) * | 2020-08-20 | 2020-12-01 | 肽源(广州)生物科技有限公司 | Chitosan-modified vitamin complex nano-liposome, preparation method thereof and application thereof in cosmetics |
| KR102379987B1 (en) | 2021-08-16 | 2022-03-30 | (주)나우코스 | Cosmetic composition comprising vitamin e derivatives and extract of mascut bailey a for improving skin elasticity and dermal density |
| CN114796119A (en) * | 2022-02-21 | 2022-07-29 | 重庆医科大学 | Composite antioxidant co-carried liposome and preparation method thereof |
| CN120360883A (en) * | 2023-12-27 | 2025-07-25 | 王叔和生物医药(武汉)有限公司 | Composite vitamin derivative nano liposome and preparation method thereof |
-
2004
- 2004-03-11 KR KR1020040016328A patent/KR20050091162A/en not_active Withdrawn
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1985280A2 (en) | 2007-04-27 | 2008-10-29 | Mibelle AG | Cosmetic product for topical use for protecting and renewing skin stem cells derived from dedifferentiated plant cells |
| CN103520101A (en) * | 2013-10-14 | 2014-01-22 | 陕西科技大学 | Vitamin A nano-emulsion and preparation method thereof |
| CN106821789A (en) * | 2017-03-30 | 2017-06-13 | 武汉润禾生物医药有限公司 | A kind of preparation method of B B-complex nourishing cream and its liposomal thing |
| CN110623858A (en) * | 2019-08-28 | 2019-12-31 | 上海克琴科技有限公司 | A kind of preparation method and application of vitamin A nano inclusion |
| CN112006924A (en) * | 2020-08-20 | 2020-12-01 | 肽源(广州)生物科技有限公司 | Chitosan-modified vitamin complex nano-liposome, preparation method thereof and application thereof in cosmetics |
| KR102379987B1 (en) | 2021-08-16 | 2022-03-30 | (주)나우코스 | Cosmetic composition comprising vitamin e derivatives and extract of mascut bailey a for improving skin elasticity and dermal density |
| CN114796119A (en) * | 2022-02-21 | 2022-07-29 | 重庆医科大学 | Composite antioxidant co-carried liposome and preparation method thereof |
| CN120360883A (en) * | 2023-12-27 | 2025-07-25 | 王叔和生物医药(武汉)有限公司 | Composite vitamin derivative nano liposome and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102451276B1 (en) | A cosmetic composition comprising particles containing high ceramide content and preparing method thereof | |
| CN112957276B (en) | Multi-effect hydroxy pinacolone retinoic acid ester nano composition and preparation method and application thereof | |
| KR100439068B1 (en) | Stablized cosmetic material containing triple layered retonol | |
| KR102223207B1 (en) | Non-aqueous oil balm type cosmetics composition | |
| KR101934208B1 (en) | Compositions for Moisturizing Skin Containing Vegetable Vernix Ingredients | |
| KR20130134532A (en) | Multilayer liquid crystal vesicle for relieving skin irritation and for recovering skin barrier, and cosmetic composition comprising the same | |
| KR20130092172A (en) | Oil-in-water solid type low irritation and high moisturizing cosmetic composition comprising polyol and emulsifier and manufacturing method thereof | |
| KR20130055069A (en) | O/w emulsion having recrystallized particle and cosmetic composition comprising thereof | |
| KR102217663B1 (en) | Cosmetic Composition For Skin Moisturizing Containing Mixture of Malva Sylvestris (Mallow) Extract, Aloe Barbadensis Leaf Extract, Dioscorea Japonica Root Extract And Hibiscus Esculentus Fruit Extract | |
| EP2832346B1 (en) | Aqueous dispersed composition | |
| JP2019043933A (en) | Oil-in-water emulsion composition and external preparation for skin | |
| KR101870514B1 (en) | Cosmetic composition comprising retinal liposome | |
| KR20050091162A (en) | Methods for manufacturing nanoemulsion and liposomes containing vitamin a, b, c, e and their derivatives and cosmetics containing it | |
| KR20190142655A (en) | Cosmetic composition containg nanoemulsion encapsulated with 7-dehydrocholesterol, cholesterol and stearic acid in inner phase of hyaluronate-ceramide NP complex | |
| KR20090009054A (en) | Cosmetic composition containing nanovegetal vitatox having antioxidant effect and wrinkle improvement | |
| KR101072198B1 (en) | Cosmetic composition for skin whitening | |
| CN112912054B (en) | Composition for strengthening skin barrier | |
| KR100482355B1 (en) | Liposome or nanoemulsion containing dipalmitoyl hydroxyproline and soy isoflavone and a cosmetic composition containing the liposome and/or the nanoemulsion and method thereof | |
| KR20060129890A (en) | Slimming cosmetic composition | |
| KR102283326B1 (en) | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment | |
| KR102547786B1 (en) | Cosmetic composition having excellent anti oxidation with improving skin tone | |
| KR20040111227A (en) | Niosome containing vitamins and amaranth oil. and Cosmetic compositions containing the same. | |
| RU2216305C1 (en) | Children's cream | |
| TW202308591A (en) | Cosmetic | |
| KR100439595B1 (en) | Tocopherol-containing Ceramide Liquid Crystal Capsule, Emulsion thereof and Cosmetic comprising the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040311 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |